These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Prevention of peritoneal adhesions with an in situ cross-linkable hyaluronan hydrogel delivering budesonide. Yeo Y, Adil M, Bellas E, Astashkina A, Chaudhary N, Kohane DS. J Control Release; 2007 Jul 31; 120(3):178-85. PubMed ID: 17582645 [Abstract] [Full Text] [Related]
9. In situ crosslinked biodegradable hydrogels loaded with IL-2 are effective tools for local IL-2 therapy. Bos GW, Jacobs JJ, Koten JW, Van Tomme S, Veldhuis T, van Nostrum CF, Den Otter W, Hennink WE. Eur J Pharm Sci; 2004 Mar 31; 21(4):561-7. PubMed ID: 14998588 [Abstract] [Full Text] [Related]
10. Auto-cross-linked hyaluronic acid gel does not reduce intra-abdominal adhesions or abscess formation in a rat model of peritonitis. Sikkink CJ, de Man B, Bleichrodt RP, van Goor H. J Surg Res; 2006 Dec 31; 136(2):255-9. PubMed ID: 17059836 [Abstract] [Full Text] [Related]
19. A randomised controlled trial on melatonin and rosiglitazone for prevention of adhesion formation in a rat uterine horn model. Aksakal O, Yilmaz B, Gungor T, Sirvan L, Sut N, Inan I, Kalyoncu S, Mollamahmutoglu L. Arch Gynecol Obstet; 2010 Jul 31; 282(1):55-61. PubMed ID: 19834723 [Abstract] [Full Text] [Related]